Menu Search
Equities

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
JIL:STU

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Actions
  • Price (EUR)0.212
  • Today's Change0.004 / 1.92%
  • Shares traded0.00
  • 1 Year change+26.95%
  • Beta0.0877
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is a China-based company principally engaged in the manufacture and distribution of traditional Chinese medicines and pharmaceutical products. The Company primarily sells its products under the Changlong and Qingtong brands. The Company's main products include Hai Kun Shen Xi Jiao Nang, small volume solution, lyophilized powder for injection, power for injection, active pharmaceutical ingredient, sterile active pharmaceutical ingredient, solid pharmacy biochemical drugs and others. The Company also makes short-term investments in the wealth management products. The Company mainly operates its businesses in the domestic market.

  • Revenue in HKD (TTM)1.04bn
  • Net income in HKD205.93m
  • Incorporated1996
  • Employees798.00
  • Location
    Jilin Province Huinan Changlong Bio-pharmacy Co LtdNo. 31 Beishan StreetChaoyang Town, Huinan CountyTONGHUA 135100ChinaCHN
  • Phone+86 4 358218333
  • Fax+86 4 358210005
  • Websitehttp://www.jlchanglong.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.